Billings, Montana

EQS-News: TeamViewer with high 44% margin and 10% revenue growth in Q3 2023; on track to reach full year guidance

Retrieved on: 
Tuesday, November 7, 2023

On the back of this, the definition of the Adjusted EBITDA changed from a Billings to a Revenue perspective.

Key Points: 
  • On the back of this, the definition of the Adjusted EBITDA changed from a Billings to a Revenue perspective.
  • During Q3, TeamViewer has worked on a major update of the Tensor solution, which was released end of October.
  • The company delivered a solid 10% revenue growth in Q3 2023 while the Adjusted (Revenue) EBITDA grew even stronger, by 19%, resulting in a high 44% margin.
  • The early extension of his contract will allow him to focus on further developing and executing TeamViewer’s growth strategy.

Par Pacific Holdings Reports Third Quarter 2023 Results

Retrieved on: 
Monday, November 6, 2023

HOUSTON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended September 30, 2023.

Key Points: 
  • HOUSTON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended September 30, 2023.
  • Third quarter 2023 Adjusted Net Income was $193.5 million, compared to $172.0 million in the third quarter of 2022.
  • Third quarter 2023 Adjusted EBITDA was $255.7 million, compared to $214.1 million in the third quarter of 2022.
  • Refining segment Adjusted EBITDA was $233.6 million in the third quarter of 2023, compared to $187.8 million in the third quarter of 2022.

Humana and Greater Good Health Expand Access to Primary Care in Montana with Opening of Senior-focused Primary Care Clinics

Retrieved on: 
Monday, October 30, 2023

Humana , a leading health and well-being company, and Greater Good Health , a healthcare organization expanding access to primary care for seniors through a nurse practitioner-led value-based care model, have announced the opening of primary care clinics in Missoula, Billings and Great Falls, Montana.

Key Points: 
  • Humana , a leading health and well-being company, and Greater Good Health , a healthcare organization expanding access to primary care for seniors through a nurse practitioner-led value-based care model, have announced the opening of primary care clinics in Missoula, Billings and Great Falls, Montana.
  • Greater Good Health’s value-based, senior-focused clinics will have a strong commitment to delivering high quality care and addressing the specific needs of senior patients through prevention, condition management, and coordinated care.
  • “Greater Good Health is focused on simplifying and coordinating care while educating and empowering seniors,” said Jesse Gamez, Humana Intermountain Medicare President.
  • “Meanwhile, seniors across Montana struggle with access to primary care, and we are responding to the needs of the community by opening comprehensive primary care clinics in partnership with Humana.

Glacier Bancorp, Inc. Announces Third Quarter Earnings Release and Conference Call

Retrieved on: 
Friday, October 6, 2023

KALISPELL, Mont., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Glacier Bancorp, Inc. (NYSE: GBCI) will report third quarter financial results after the market closes on October 19, 2023.

Key Points: 
  • KALISPELL, Mont., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Glacier Bancorp, Inc. (NYSE: GBCI) will report third quarter financial results after the market closes on October 19, 2023.
  • A conference call for investors is scheduled for 11:00 a.m. Eastern Time on Friday, October 20, 2023.
  • Please note that our conference call host no longer offers a general dial-in number.
  • Investors who would like to join the call may now register by following this link to obtain dial-in instructions: https://register.vevent.com/register/BIbe718214dea94214b3ab02d160926dd0
    To participate via the webcast, log on to: https://edge.media-server.com/mmc/p/w8zz3hr8
    If you are unable to participate during the live webcast, the call will be archived on our website, www.glacierbancorp.com .

Par Pacific Holdings Reports Strong Second Quarter 2023 Results

Retrieved on: 
Monday, August 7, 2023

HOUSTON, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended June 30, 2023.

Key Points: 
  • HOUSTON, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended June 30, 2023.
  • Second quarter 2023 Adjusted Net Income was $105.6 million, compared to an Adjusted Net Income of $197.2 million in the second quarter of 2022.
  • Second quarter 2023 Adjusted EBITDA was $150.8 million, compared to $242.1 million in the second quarter of 2022.
  • Adjusted Gross Margin for the Refining segment was $205.6 million in the second quarter of 2023, compared to $287.3 million in the second quarter of 2022.

Cardlytics Announces Second Quarter 2023 Financial Results

Retrieved on: 
Tuesday, August 1, 2023

ATLANTA, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the second quarter ended June 30, 2023.

Key Points: 
  • ATLANTA, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the second quarter ended June 30, 2023.
  • Revenue was $76.7 million, an increase of 2% year-over-year, compared to $75.4 million in the second quarter of 2022.
  • Cardlytics MAUs were 188.1 million, an increase of 5% year-over-year, compared to 179.9 million in the second quarter of 2022.
  • Cardlytics ARPU was $0.38 in each of the second quarter of 2023 and 2022.

Glacier Bancorp, Inc. Announces Second Quarter Earnings Release and Conference Call

Retrieved on: 
Thursday, July 13, 2023

KALISPELL, Mont., July 13, 2023 (GLOBE NEWSWIRE) -- Glacier Bancorp, Inc. (NYSE: GBCI ) will report second quarter financial results after the market closes on July 20, 2023.

Key Points: 
  • KALISPELL, Mont., July 13, 2023 (GLOBE NEWSWIRE) -- Glacier Bancorp, Inc. (NYSE: GBCI ) will report second quarter financial results after the market closes on July 20, 2023.
  • A conference call for investors is scheduled for 11:00 a.m. Eastern Time on Friday, July 21, 2023.
  • Please note that our conference call host no longer offers a general dial-in number.
  • Investors who would like to join the call may now register by following this link to obtain dial-in instructions: https://register.vevent.com/register/BI19db5b01086643a5bde0e9f301e797ea
    To participate via the webcast, log on to: https://edge.media-server.com/mmc/p/6gianovu
    If you are unable to participate during the live webcast, the call will be archived on our website, www.glacierbancorp.com .

Former Assistant Secretary of US Air Force appointed to chair Global Airlines Advisory Board

Retrieved on: 
Tuesday, June 6, 2023

LONDON, June 6, 2023 /PRNewswire/ -- Global Airlines, the world's newest long-haul airline, has announced the appointment of Kevin Billings as the chair of its Advisory Board.

Key Points: 
  • LONDON, June 6, 2023 /PRNewswire/ -- Global Airlines, the world's newest long-haul airline, has announced the appointment of Kevin Billings as the chair of its Advisory Board.
  • Kevin is the first member officially appointed to the Board, with a plethora of industry experts and aviation enthusiasts lined up to be appointed in the weeks ahead.
  • James Asquith, CEO and Founder of Global Airlines said, "I am delighted that Kevin has joined our team in this important role.
  • Global Airlines is now focused on working closely with the relevant authorities and partners in preparation for inaugural flights in the Spring of 2024.

Former Assistant Secretary of US Air Force appointed to chair Global Airlines Advisory Board

Retrieved on: 
Tuesday, June 6, 2023

LONDON, June 6, 2023 /PRNewswire/ -- Global Airlines, the world's newest long-haul airline, has announced the appointment of Kevin Billings as the chair of its Advisory Board.

Key Points: 
  • LONDON, June 6, 2023 /PRNewswire/ -- Global Airlines, the world's newest long-haul airline, has announced the appointment of Kevin Billings as the chair of its Advisory Board.
  • Kevin is the first member officially appointed to the Board, with a plethora of industry experts and aviation enthusiasts lined up to be appointed in the weeks ahead.
  • James Asquith, CEO and Founder of Global Airlines said, "I am delighted that Kevin has joined our team in this important role.
  • Global Airlines is now focused on working closely with the relevant authorities and partners in preparation for inaugural flights in the Spring of 2024.

Endogenex™ Appoints Christopher Sorli as Chief Medical Officer

Retrieved on: 
Thursday, May 18, 2023

MINNEAPOLIS, May 18, 2023 /PRNewswire/ -- Endogenex, Inc., a clinical stage medical device company, is proud to announce the addition of Christopher Sorli, M.D., Ph.D., as Chief Medical Officer (CMO). Dr. Sorli brings a wealth of experience and clinical expertise to the company's leadership team further strengthening Endogenex's commitment to innovation that drives improvement in patient outcomes. As CMO, Dr. Sorli will play a pivotal role in shaping Endogenex's strategic medical vision and draw upon an extensive clinical background to lead medical affairs activities, collaborate with regulatory agencies, and establish relationships with healthcare professionals and patients that will advance Endogenex's position in the medical device industry.

Key Points: 
  • Bringing expertise in diabetes management, medical and regulatory affairs, clinical research, and market access
    MINNEAPOLIS, May 18, 2023 /PRNewswire/ -- Endogenex, Inc., a clinical stage medical device company, is proud to announce the addition of Christopher Sorli, M.D., Ph.D., as Chief Medical Officer (CMO).
  • Dr. Sorli joins Endogenex from Acerus Pharmaceutical where he was Chief Medical Officer leading the development of products that improve patient experience, with a primary focus in the field of Men's Health.
  • Dr. Sorli was also the Vice President and Head of Diabetes for US Medical at Sanofi where he led US medical strategy and medical activities for established and developmental portfolios of diabetes products.
  • Dr. Sorli also led The Center of Excellence in Diabetes and Metabolism, a clinical research center and metabolic surgery program.